| Full Name | Luke Egan |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1 Mellon Way, Latrobe, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053095877 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MT229452 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Luke Egan, MD 224 S 6th St, Youngwood, PA 15697-1218 Ph: (724) 433-1972 | Luke Egan, MD 1 Mellon Way, Latrobe, PA 15650-1197 Ph: (724) 537-1207 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging TNF-alpha inhibitors and interleukin inhibitors will drive the psoriasis drug market to increase from $3 billion in 2008 to $5.2 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Quickly detecting and identifying dangerous biotoxins is now a reality, thanks to the xMAP Biothreat Toxin Panel (BTP) by Luminex. The xMAP Biothreat Toxin Panel is the first multiplex assay to rapidly detect and identify the six most easily acquired and most dangerous biotoxins. All six of these biotoxins are on the US government's list of most dangerous substances.
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,046 patients with advanced breast cancer that met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa.
Our sense of belonging to the male or female gender is an inherent component of the human identity perception. As a general rule, gender identity and physical sex coincide. If this is not the case, one refers to trans-identity or transsexuality. In a current study, brain researcher Georg S. Kanz of the University Clinic for Psychiatry and Psychotherapy of the MedUni Vienna was able to demonstrate that the very personal gender identity of every human being is reflected and verifiable in the cross-links between brain regions.
A first-in-human study featured in the February issue of The Journal of Nuclear Medicine reports that the novel positron emission tomography/computed tomography tracer 18F-GP1 showed excellent image quality and a high detection rate for the diagnosis of acute venous thromboembolism.
› Verified 5 days ago
Dr. Christopher C. Drescher, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Mellon Way, Latrobe, PA 15650 Phone: 724-537-1207 | |
Karren Vlahos, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 121 W 2nd Ave, Latrobe, PA 15650 Phone: 724-537-1207 | |
Emily Katherine Fellin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Mellon Way, Latrobe Family Medicine Residency Program, Latrobe, PA 15650 Phone: 724-537-1485 | |
Dr. Francis E Meyers, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 555 Route 217, Suite 5, Latrobe, PA 15650 Phone: 724-694-0274 Fax: 724-694-0383 | |
Dr. Anna Nash Gorman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Mellon Way, Latrobe, PA 15650 Phone: 724-537-1207 | |
Teresa Beth Malec, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Mellon Way, Latrobe Family Medicine Residency Program, Latrobe, PA 15650 Phone: 724-537-1485 |